(1)
Acikgoz, Y.; Ergun, Y.; Ucar, G.; Dirikoc, M.; Uncu, D. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-Positive Metastatic Breast Cancer Patients. Acta Medica 2019, 50, 14-19.